ANASTASYS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ANASTASYS
Largest movements
- Receivables within one year -€5,147
down €5,147 (-74.8%), from €6,881 to €1,734
of which Other amounts receivable: -€5,088
- Cash +€1,187
up €1,187 (+1,094%), from €108 to €1,295
mainly Receivables within one year (+€5,147) and Other debts (+€4,222)
- Tangible fixed assets -€139
down €139 (-7.0%), from €1,984 to €1,845
- Profit (loss) carried forward -€8,321
down €8,321 (-24.0%), from -€34,740 to -€43,061
- Other debts +€4,222
up €4,222 (+14.2%), from €29,823 to €34,045
- Gross operating margin +€1,211
up €1,211 (+13.0%), from -€9,333 to -€8,122
- Depreciation -€203
down €203 (-59.5%), from €342 to €139
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,343 | €5,244 | -€4,099 | -43.9% |
| Fixed assets | 21/28 | €1,984 | €1,845 | -€139 | -7.0% |
| Tangible fixed assets | 22/27 | €1,984 | €1,845 | -€139 | -7.0% |
| Plant, machinery and equipment | 23 | €1,984 | €1,845 | -€139 | -7.0% |
| Current assets | 29/58 | €7,359 | €3,399 | -€3,960 | -53.8% |
| Stocks and contracts in progress | 3 | €370 | €370 | = | 0.0% |
| Stocks | 30/36 | €370 | €370 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €6,881 | €1,734 | -€5,147 | -74.8% |
| Trade receivables | 40 | €1,371 | €1,312 | -€59 | -4.3% |
| Other amounts receivable | 41 | €5,510 | €422 | -€5,088 | -92.3% |
| Cash at bank and in hand | 54/58 | €108 | €1,295 | +€1,187 | +1,094% |
| Total equity and liabilities | 10/49 | €9,343 | €5,244 | -€4,099 | -43.9% |
| Equity | 10/15 | -€20,480 | -€28,801 | -€8,321 | -40.6% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€34,740 | -€43,061 | -€8,321 | -24.0% |
| Amounts payable | 17/49 | €29,823 | €34,045 | +€4,222 | +14.2% |
| Amounts payable within one year | 42/48 | €29,823 | €34,045 | +€4,222 | +14.2% |
| Other amounts payable | 47/48 | €29,823 | €34,045 | +€4,222 | +14.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €342 | €139 | -€203 | -59.5% |
| Gross operating margin | 9900 | -€9,333 | -€8,122 | +€1,211 | +13.0% |
| Operating profit (loss) | 9901 | -€9,675 | -€8,260 | +€1,415 | +14.6% |
| Financial income | 75/76B | - | €3 | +€3 | |
| Recurring financial income | 75 | - | €3 | +€3 | |
| Financial charges | 65/66B | €54 | €64 | +€10 | +18.4% |
| Recurring financial charges | 65 | €54 | €64 | +€10 | +18.4% |
| Profit (loss) for the period before taxes | 9903 | -€9,729 | -€8,321 | +€1,408 | +14.5% |
| Profit (loss) for the period | 9904 | -€9,729 | -€8,321 | +€1,408 | +14.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€9,729 | -€8,321 | +€1,408 | +14.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.